|
EP2298900A1
(en)
|
1996-09-17 |
2011-03-23 |
Novartis Vaccines and Diagnostics, Inc. |
Compositions and methods for treating intracellular diseases
|
|
MX343752B
(es)
|
1998-05-01 |
2016-11-22 |
Novartis Vaccines & Diagnostics Inc |
Antigenos de neisseria meningitidis y composiciones que los contienen.
|
|
AU2109700A
(en)
|
1999-01-22 |
2000-08-07 |
Smithkline Beecham Biologicals (Sa) |
Novel compounds
|
|
US7666988B1
(en)
|
1999-03-12 |
2010-02-23 |
Glaxosmithkline Biologicals S.A. |
BASB082 Polypeptides
|
|
NZ571167A
(en)
|
1999-04-30 |
2010-05-28 |
Novartis Vaccines & Diagnostic |
Fragments from Neisseria protein ORF 953 and their use in medicaments and diagnostic reagents
|
|
EP1179072A2
(en)
|
1999-05-19 |
2002-02-13 |
Chiron S.P.A. |
Combination neisserial compositions
|
|
PT2275551E
(pt)
|
1999-10-29 |
2015-06-29 |
Novartis Vaccines & Diagnostic |
Péptidos antigénicos de neisseria
|
|
GB9928196D0
(en)
|
1999-11-29 |
2000-01-26 |
Chiron Spa |
Combinations of B, C and other antigens
|
|
ES2588917T3
(es)
|
2000-01-17 |
2016-11-07 |
Glaxosmithkline Biologicals Sa |
Vacuna de VME suplementada contra meningococo
|
|
AU2818101A
(en)
*
|
2000-01-25 |
2001-08-07 |
University Of Queensland, The |
proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA
|
|
PT2270030E
(pt)
|
2000-02-28 |
2012-07-24 |
Novartis Vaccines & Diagnostic |
Expressão heteróloga de proteínas de neisseria
|
|
GB0011108D0
(en)
*
|
2000-05-08 |
2000-06-28 |
Microscience Ltd |
Virulence gene and protein and their use
|
|
MXPA03000822A
(es)
|
2000-07-27 |
2004-11-01 |
Childrens Hosp & Res Ct Oak |
Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis.
|
|
GB0107219D0
(en)
*
|
2001-03-22 |
2001-05-16 |
Microbiological Res Authority |
Immunogenic commensal neisseria sequences
|
|
GB0108024D0
(en)
*
|
2001-03-30 |
2001-05-23 |
Chiron Spa |
Bacterial toxins
|
|
RU2355704C2
(ru)
*
|
2001-04-17 |
2009-05-20 |
Новартис Вэксинс Энд Диагностикс, Инк |
Моноклональное антитело, направленное против gna33 пептида, и его применение
|
|
JP2004529643A
(ja)
*
|
2001-04-17 |
2004-09-30 |
カイロン コーポレイション |
機能活性抗体を誘発する髄膜炎菌性ｂエピトープの分子模倣物
|
|
CU23245A1
(es)
|
2001-07-16 |
2007-10-17 |
Inst De Medicina Tropical Pedr |
CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS
|
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
|
GB0121591D0
(en)
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
|
ES2615362T3
(es)
|
2001-07-27 |
2017-06-06 |
Glaxosmithkline Biologicals Sa |
Adhesinas de meningococos
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
AU2003239125A1
(en)
|
2002-03-20 |
2003-10-08 |
Emory University |
Neisseria mutants, lipooligosaccharides and immunogenic compositions
|
|
CN1674933B
(zh)
*
|
2002-08-02 |
2012-09-26 |
葛兰素史密丝克莱恩生物有限公司 |
疫苗组合物
|
|
US7785608B2
(en)
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
|
EP2351579B1
(en)
|
2002-10-11 |
2016-09-21 |
Novartis Vaccines and Diagnostics S.r.l. |
Polypeptide vaccines for broad protection against hypervirulent meningococcal lineages
|
|
US7807802B2
(en)
|
2002-11-12 |
2010-10-05 |
Abbott Lab |
Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
|
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
DK1587537T3
(da)
*
|
2003-01-30 |
2012-07-16 |
Novartis Ag |
Injicerbare vacciner mod multiple meningococ-serogrupper
|
|
CU23237A1
(es)
|
2003-12-03 |
2007-09-26 |
Ct Ingenieria Genetica Biotech |
PROTEINA NMB1125 Y SU USO EN FORMULACIONES FARMACéUTICAS
|
|
GB0408977D0
(en)
|
2004-04-22 |
2004-05-26 |
Chiron Srl |
Immunising against meningococcal serogroup Y using proteins
|
|
CN101107007B
(zh)
|
2005-01-27 |
2011-08-17 |
奥克兰儿童医院及研究中心 |
对脑膜炎奈瑟球菌所致疾病具有广谱保护作用的gna1870囊泡疫苗
|
|
AU2006214064B2
(en)
|
2005-02-18 |
2012-04-26 |
J. Craig Venter Institute, Inc. |
Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
|
|
JP2008530245A
(ja)
|
2005-02-18 |
2008-08-07 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド |
尿路病原性菌株由来の抗原
|
|
WO2006096527A2
(en)
*
|
2005-03-04 |
2006-09-14 |
Diversa Corporation |
Nucleic acids and proteins and methods for making and using them
|
|
CU23578A1
(es)
|
2005-09-16 |
2010-09-30 |
Ct Ingenieria Genetica Biotech |
Proteína de la cápsida del virus dengue inductora de respuesta protectora y composición vacunal
|
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
|
CU23549A1
(es)
*
|
2005-12-29 |
2010-07-20 |
Ct Ingenieria Genetica Biotech |
Composiciones farmacéuticas que contienen la proteína nma0939
|
|
AU2007263531B2
(en)
|
2006-06-29 |
2012-03-15 |
J. Craig Venter Institute, Inc. |
Polypeptides from neisseria meningitidis
|
|
EP2586790A3
(en)
|
2006-08-16 |
2013-08-14 |
Novartis AG |
Immunogens from uropathogenic Escherichia coli
|
|
CU23630A1
(es)
|
2006-10-30 |
2011-02-24 |
Ct Ingenieria Genetica Biotech |
Moléculas peptídicas quiméricas con propiedades antivirales contra los virus de la familia flaviviridae
|
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
|
TW200902708A
(en)
|
2007-04-23 |
2009-01-16 |
Wyeth Corp |
Methods of protein production using anti-senescence compounds
|
|
GB0713880D0
(en)
|
2007-07-17 |
2007-08-29 |
Novartis Ag |
Conjugate purification
|
|
AU2009215364B2
(en)
|
2008-02-21 |
2014-09-18 |
Glaxosmithkline Biologicals S.A. |
Meningococcal fHBP polypeptides
|
|
CN104548082A
(zh)
|
2009-03-24 |
2015-04-29 |
诺华股份有限公司 |
为脑膜炎球菌因子h结合蛋白添加佐剂
|
|
CA2761916A1
(fr)
|
2009-05-14 |
2010-11-18 |
Sanofi Pasteur |
Procede pour adjuver le lipopolysaccharide (lps) des bacteries a gram-negatif
|
|
WO2011161653A1
(en)
|
2010-06-25 |
2011-12-29 |
Novartis Ag |
Combinations of meningococcal factor h binding proteins
|
|
CA2808975C
(en)
|
2010-08-23 |
2018-10-30 |
Wyeth Llc |
Stable formulations of neisseria meningitidis rlp2086 antigens
|
|
KR101584871B1
(ko)
|
2010-09-10 |
2016-01-22 |
와이어쓰 엘엘씨 |
네이세리아 메닝기티디스 orf2086 항원의 비-지질화된 변이체
|
|
CA2810971C
(en)
|
2010-09-10 |
2020-11-03 |
Novartis Ag |
Developments in meningococcal outer membrane vesicles
|
|
CA2865745C
(en)
|
2012-03-09 |
2018-01-09 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
|
ES2847923T3
(es)
|
2012-06-14 |
2021-08-04 |
Glaxosmithkline Biologicals Sa |
Vacunas contra el meningococo del serogrupo X
|
|
CN104736563A
(zh)
|
2012-07-27 |
2015-06-24 |
国家健康与医学研究院 |
Cd147作为受体用于脑膜炎球菌至血管内皮的菌毛介导的粘附
|
|
CA2903716C
(en)
|
2013-03-08 |
2019-04-09 |
Pfizer Inc. |
Immunogenic fusion polypeptides
|
|
RU2662968C2
(ru)
|
2013-09-08 |
2018-07-31 |
Пфайзер Инк. |
Иммуногенная композиция против neisseria meningitidis (варианты)
|
|
KR20190049940A
(ko)
|
2015-02-19 |
2019-05-09 |
화이자 인코포레이티드 |
나이세리아 메닌지티디스 조성물 및 그의 방법
|
|
WO2017137085A1
(en)
|
2016-02-11 |
2017-08-17 |
Sanofi Pasteur |
Meningitidis vaccines comprising subtilinases
|
|
SG11201906519RA
(en)
|
2017-01-31 |
2019-08-27 |
Pfizer |
Neisseria meningitidis compositions and methods thereof
|
|
US12084704B2
(en)
*
|
2017-05-10 |
2024-09-10 |
Global Bioenergies |
Methods for producing isobutene from 3-methylcrotonic acid
|
|
WO2019018744A1
(en)
|
2017-07-21 |
2019-01-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
IMMUNOGENIC COMPOSITIONS OF NEISSERIA MENINGITIDIS
|
|
WO2020023717A2
(en)
*
|
2018-07-25 |
2020-01-30 |
The Trustees Of Indiana University |
Diagnostic assay for a strain of neisseria meningitidis
|
|
CA3155669A1
(en)
|
2019-09-27 |
2021-04-01 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
CN113136444B
(zh)
*
|
2021-05-10 |
2024-04-19 |
临沂大学 |
医用食品中海氏肠球菌的微滴数字pcr检测方法
|
|
CN116162140B
(zh)
*
|
2022-07-19 |
2025-09-09 |
四川大学华西医院 |
一种幽门螺杆菌重组抗原蛋白SecG及其制备方法与应用
|
|
WO2025006737A1
(en)
|
2023-06-30 |
2025-01-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Genetically detoxified mutant of neisseria and outer membrane vesicle (omv) vaccine
|
|
CN119792505A
(zh)
*
|
2023-10-10 |
2025-04-11 |
康希诺生物股份公司 |
一种抗脑膜炎球菌的免疫组合物及其用途
|